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hnRNPA2 as a coactivatorPathophysiological conditions causing mitochondrial dysfunction and altered transmembrane potential
(Δψm) initiate a mitochondrial respiratory stress response, also known as mitochondrial retrograde
response, in a variety of mammalian cells. An increase in the cytosolic Ca2+ [Ca2+]c as part of this signaling
cascade activates Ca2+ responsive phosphatase, calcineurin (Cn). Activation of IGF1R accompanied by
increased glycolysis, invasiveness, and resistance to apoptosis is a phenotypic hallmark of C2C12 skeletal
muscle cells subjected to this stress. The signaling is associated with activation and increased nuclear
translocation of a number of transcription factors including a novel NFκB (cRel:p50) pathway, NFAT, CREB
and C/EBPδ. This culminates in the upregulation of a number of nuclear genes including Cathepsin L, RyR1,
Glut4 and Akt1. We observed that stress regulated transcription activation of nuclear genes involves a
cooperative interplay between NFκB (cRel:p50), C/EBPδ, CREB, and NFAT. Our results show that the
functional synergy of these factors requires the stress-activated heterogeneous nuclear ribonucleoprotein,
hnRNPA2 as a transcriptional coactivator. We report here that mitochondrial stress leads to induced
expression and activation of serine threonine kinase Akt1. Interestingly, we observe that Akt1
phosphorylates hnRNPA2 under mitochondrial stress conditions, which is a crucial step for the recruitment
of this coactivator to the stress target promoters and culmination in mitochondrial stress-mediated
transcription activation of target genes. We propose that mitochondrial stress plays an important role in
tumor progression and emergence of invasive phenotypes.iology, School of Veterinary
19104, USA. Tel.: +1 215 898
ani).
lsevier B.V.© 2010 Published by Elsevier B.V.1. Introduction
Mitochondria are important organelles that participate in a myriad
of metabolic, biosynthetic and bioenergetic functions. In addition to
generating ATP, mitochondria play important role in the integration of
metabolism, regulation of calcium signaling and execution of cell
death [1]. In the cellular context, mitochondria are highly susceptible
to injury from hypoxia, environmental chemicals, and pharmacolog-
ical agents. Additionally, mitochondria are not only amajor site of ROS
production, but are also highly vulnerable to ROS mediated mem-
brane damage [2]. All these agents potentially induce mutations in
mitochondrial DNA (mtDNA), and/or, loss of mtDNA, resulting in the
disruption of mitochondrial function and membrane potential (Δψm)
[3–5]. Mitochondrial dysfunction triggers a signaling pathway which
culminates in a large scale reprogramming of nuclear gene expression
pattern [6–8]. In yeast and also in mammalian cells the “retrograde
response” or “mitochondrial respiratory stress” is one mechanism bywhich cells respond to altered mitochondrial function. The signaling
mechanism involved in retrograde response has been studied in a
wide spectrum of cells ranging from yeast to mammalian cells. While
the yeast response occurs mainly by the activation of the RTG
pathway, mammalian cell response involves more complex signaling
[3,9–14].
Mitochondrial dysfunction due to partial or complete depletion of
mitochondrial DNA (mtDNA) triggers a speciﬁc mitochondrial stress
signaling in C2C12 skeletal myoblasts, A549 lung carcinoma cells, and
others [3,5,14,15,17]. This is characterized by elevated cytosolic calcium
([Ca2+]c) leading to activation of calcineurin-dependent NFκB pathway.
The mitochondrial stress-induced NFκB pathway differs from the
established canonical and non-canonical pathways and involves the
release of p50:cRel heterodimer from IκBβ in the cytosol through
calcineurin-mediated dephosphorylation of IκBβ [6,16]. In 143B
osteosarcoma cells, mitochondrial stress resulting from mtDNA deple-
tion or proteinmisfolding caused activation of CREB, and a C/EBP family
factor CHOPS, respectively [17,18]. These same transcription factors
have been implicated in the regulation of a number of nuclear marker
genes that respond to mitochondrial respiratory stress signaling in
different cells. Currently there is increasing evidence that mtDNA
content directly reﬂects on the metabolic state of cells [19–22].
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increased expression of genes encoding glucose transporters and
glycolytic enzymes [23]. A number of recent studies show that
proliferating tumors in both human patients and animal models
contain mutated or deleted mtDNA and/or dysfunctional mitochon-
dria [13,24,25]. In C2C12 and A549 cells, mtDNA depletion induced
cell proliferation and resistance to apoptosis [3,9–11,15,26]. We have
previously shown that selective inhibition of IR autophosphorylation
and Cn-dependent activation of the IGF1R pathway are the bases for
increased glucose utilization and cell proliferation in C2C12 rhabdo-
myoblasts subjected to mitochondrial respiratory stress by mtDNA
depletion [26].
Similar to yeast, the transcriptional targets of the retrograde
pathway in mammalian cells are diverse and include proteins that
regulate Ca2+ storage and release, glucose uptake and metabolism,
mitochondrial energy transduction, cell survival, and cytoskeletal
organization [3,9,17,26–28]. Although several potential target genes
of the mammalian mitochondrial stress pathway have been identiﬁed
in different cells [6,7], the full genetic footprint of mitochondrial stress
has not been characterized. Characterization of the genes regulated by
the retrograde pathway is central to understanding the putative role
of mitochondrial stress in cellular resistance to apoptosis, aging,
cancer progression, and neural and bone degenerative diseases.
We show that the regulation of mitochondrial respiratory stress
responsive nuclear genes requires physical interactions and functional
synergy between the transcriptional activators NFκB (cRel:p50),
C/EBPδ, CREB, and NFAT that are activated under mitochondrial stress
conditions. In addition, we have found that the functional synergy of
these factors in the mitochondrial stress pathway requires coactiva-
tion of heterogeneous nuclear ribonucleoprotein (hnRNP) A2 [14].
Furthermore, we show that the oncogenic kinase Akt1 is activated in
the nucleus under mitochondrial stress and phosphorylation of
hnRNPA2 by Akt1 is essential for the recruitment of hnRNPA2 to the
enhanceosome complexes of stress target promoters.
2. Materials and methods
2.1. Plasmid constructs and cloning
The mouse Cathepsin L gene promoter DNA (sequence −273 to
+47) [9] and the mouse RyR1 promoter (sequence −205 to +63)
(accession # FJ480190) were ampliﬁed from mouse genomic DNA [9]
and cloned into the pGL3 mammalian expression vector (Promega,
Madison WI). The human Glut 4 promoter (sequence −1209 to
−168) [29] was subcloned in the pGL3 vector. The cRel, C/EBPδ, NFAT
and CREB genes were cloned into the pCMV4 expression vector.
HnRNP A2 cDNA was subcloned from pET28a (+) vector [14] into pCI
for transfections of C2C12 cells.
2.2. Cell lines and transient transfections
Murine C2C12 skeletal myoblasts (CRL1772, ATCC, Manassas, VA)
were grown in Dulbecco's Modiﬁed Eagle's medium (Invitrogen,
Carlsbad, CA) supplemented with 10% fetal bovine serum and 0.1%
gentamycin. MtDNA-depleted clones containing ∼80% reduced
mtDNA contents were generated by ethidium bromide treatment
(100 ng/ml) as previously described [3] and grown in the presence of
1 mM sodium pyruvate and 50 μg/ml uridine. Frozen aliquots of cells
derived from the same mtDNA-depleted clone were used in all
experiments reported in this study to ensure uniform level of mtDNA
depletion. Additionally, mtDNA contents of various cell lines were
routinely measured at every third passage of cells by PCR.
Reverted cells represent mtDNA-depleted cells (with 80% DNA
depletion) grown for 30 cycles in the absence of ethidium bromide
until the mtDNA content reached 20% of the control cell level. In some
experiments an alternatemethod of mitochondrial stress induction bytreatment with mitochondria speciﬁc uncoupler, CCCP (25 µM) was
used. In these experiments CCCP treatment was carried out for up to
5 h as speciﬁed.
Transfections were carried out using Fugene 6 reagent (Roche
Applied Science, Indianapolis, IN) following the manufacturer's
suggested protocol. Promoter DNA constructs cloned in pGL3 vector
(1 μg) and 0.5 μg of a renilla luciferase construct (Promega) was used
as an internal control. The luciferase activity was assayed using the
Dual-Luciferase reporter assay system from Promega. Cotransfections
with various cDNAs were carried out in 6-well plates using 0.2 μg of
cDNA constructs.
2.3. mRNA knock down by siRNA expression
Predesigned siRNAs for mouse CnAα (ID #292199), IGF1R (ID
#159115), IR (ID #67808), Akt1 (ID #162426) and negative controls
(scrambled siRNA) were purchased from Ambion Inc. (Austin, TX).
Control and mtDNA-depleted cells (104 cells/well) were transfected
with pre-annealed double-stranded siRNAs at a ﬁnal concentration of
30 nM by the method of reverse transfection. Transient transfections
were carried out in triplicate using siPORT NeoFX reagent (Ambion
Inc). RNA was isolated 48 h after transfections using TRIzol reagent
(Invitrogen), and the level of silencing of CnAα, IGF1R, and IR mRNA
was quantiﬁed by real-time PCR.
2.4. Generation of stable hnRNPA2 silenced cell lines
Knock down of hnRNPA2 mRNA by stable expression of siRNA in
C2C12 cells was described before [14]. Stable cell lines were generated
after transfection (Fugene 6, Roche) of mtDNA-depleted C2C12 cells
with hnRNPA2si3-pSilencer2.1neo (or pSilencer2.1neo vector alone)
containing a neomycin resistance gene. Stably transduced cells were
selected using G418 (1 mg/ml) as a selection marker.
2.5. Knock down of IκBβ and IκBα mRNAs by retrovirus
Two siRNA sequences targeting mouse IκBβ (5′-GACTGGAGGCTA-
CAACTAG-3′ and 5′-CAGAGATGAGGGCGATGAA-3′) were designed
and cloned into pSilencer 1.0-U6 vector (Ambion). Empty pSilencer
1.0-U6 vector was used as control. Control and siRNA vector were
cotransfected with neomycin-resistant pcDNA3 vector (Invitrogen)
into control and depleted cells. G418 (1 mg/ml) was added to the
medium for selection. Two siRNA sequences against mouse IκBα (5′-
AGGCCAGCGTCTGACATTA3-′ and 5′-GGCCAGCGTCTGACATTAT-3′)
were cloned in pSUPER puro vector (OligoEngine). 293T cells were
transduced with the retroviral clones and the vector alone. The
medium used for transducing control and mtDNA-depleted cells with
the viral constructs contained 6 μg/ml polybrene. Positive cloneswere
selected in the presence of 10 μg/ml of puromycine for control cells
and 100 μg/ml puromycine for depleted cells because the latter cells
were resistant to lower dose of the antibiotic. After 3 weeks, well
separated individual colonies were picked and grown. The protein
levels of IκBβ and IκBα were measured by Western blot using
antibodies against respective proteins (Santa Cruz Biotechnology).
Cells with b50% reduced IκBβ or IκBα levels compared with their
respective controls were used for further characterization [6].
2.6. Uptake of 2-deoxyglucose
Glucose uptake was measured as described previously [26,30].
Brieﬂy, 106 cells grown in 6-well plates were serum-starved for 6 h,
and incubated in the presence or absence of indicated levels of insulin
for 30 min in glucose-free medium. One microcurie of 2-[3H]
deoxyglucose (1 mCi/0.1 mmol; American Radiolabeled Chemicals,
St. Louis, MO) was added to each well containing 2 ml of medium for
an additional 15 min. The transport was terminated by washing cells
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of the lysates were counted in liquid scintillation counter (Beckman
Instruments, Fullerton, CA).
2.7. Growth pattern and in vitro invasion assays
Growth patterns were measured by seeding cells at a density of
1×104 cells/well in 24-well culture plates. Cells from three wells at
each time point were harvested and counted using Viacount reagent
(Guava technologies) in a personal cytometer according to the
manufacturer's protocols (Guava Technologies, Hayward, CA). The in
vitro invasion assays were carried out in Matrigel invasion chambers
(BD Biosciences Discovery Labware, Bedford, MA) as described
previously [14]. Cells (1×104) were seeded on top of the Matrigel
layer. After incubation for 24 h at 37 °C, non-invading cells in the
Matrigel layer were removed, and the microporous membranes
containing invaded cells were stained and viewed with a BX 61
ﬂuorescence microscope (Olympus America, Center Valley, PA) as
described previously [9]. At least six ﬁelds were examined for each
condition per experiment.
2.8. Calcineurin activity assay
Calcineurin activity was assayed according to Antoni et al. with the
following modiﬁcations [31]. Total serine/threonine phosphatase
activity was ﬁrst determined by incubating cell lysate (2 μg) from
untreated, AICAR (2 mM, 2 h), and FK506 (10 nM, 30 min) treated cells
with threonine phosphopeptide (Upstate, Cat. no. 12-219) in a ﬁnal
volume of 25 μl for 20 min at 30 °C in 50 μM Tris-Cl, pH 7.0, 0.1 mM
CaCl2. The phosphate released was quantitated by incubating with
100 μl ofmalachite green andmeasuring the absorbance at 660 nmafter
15 min. Inparallel, control incubations containingphosphatase inhibitor
mix I (NaF, 5 mM;okadaic acid, 500 nM;orthovanadate, 100 μM;FK506,
1 nM; calyculin, 0.1 μM; and cyclosporine A, 100 μM) and phosphatase
inhibitor mix II (FK506, 1 nM; calyculin, 0.1 μM; and cyclosporine A,
100 μM) were also carried out. Nonspeciﬁc phosphatase activity under
these conditions was subtracted from total serine/threonine phospha-
tase activity referred to as corrected activity. Calcineurin activity was
calculated by subtracting the activity in the presence of added
phosphatase inhibitor mix II from the corrected activity (obtained
after subtracting the non-speciﬁc activity).
2.9. Annexin V assay
The assay for cells undergoing apoptosis was performed using a
Nexin Kit (Guava Technologies, Hayward, CA) according to the
manufacturer's suggested protocol. Cells (106 each) treated without
or with inhibitors (Genistein, 0.1 mg/ml; AG1024, 10 μM; and PPP,
2.5 μM) for 2 h were washed with 1 ml of 1× Nexin Buffer (Guava
Technologies) and resuspended in the same buffer. After labeling with
Annexin V-PE, the percentage of apoptotic cells was quantiﬁed using a
Personal Cytometer (Guava Technologies). In case of siRNA experi-
ments, cells were harvested 48 h after the siRNA transfections and
counted as described above.
2.10. Microarray analysis
Total RNA from control, mtDNA-depleted, IκBβ knock down (KD)/
control, and IκBβ KD/depleted C2C12 cells was isolated using TRIzol
according to the manufacturer's instructions. RNA was analyzed on
MOE430A chips (Affymetrix). Statistical signiﬁcance established with
Partek (two-way analysis of variance signiﬁcant to b0.0005). Gene
selection was performed using the Spotﬁre program as described
before [6]. The total number of spots matching criteria was 43,
representing 25 Gene Ontology header-mapped genes with known
functions.2.11. Enhanceosome pull-down
Nuclear extracts were prepared by the method of Dignam et al.
[32]. RNA bound to the proteins was removed by RNAse treatment.
PCR ampliﬁed DNA corresponding to sequence −273 to −53 of the
mouse Cathepsin L promoter was coupled to cyanogen bromide-
activated Sepharose 4B as described previously [32]. Approximately
1 mg of protein was loaded per DNA-Sepharose column as described
previously [33], and bound proteins were eluted with 0.2–0.4 M KCl
buffer containing 25 mM HEPES, pH 7.8, 12.5 mM MgCl2, 1 mM
dithiothreitol, 20% (vol/vol) glycerol, and 0.1% (vol/vol) Nonidet P-
40. Eluates (200 µl each) were concentrated to 20 µl and run on a 12%
SDS-PAGE gel and silver stained using a Silver Stain Plus kit (Bio-Rad
Laboratories, Hercules, CA). The immunoblots were developed using
SuperSignal West Femto maximum sensitivity substrate from Pierce
Chemical (Rockford, IL).
2.12. Immunoprecipitation
Equal amounts of input hnRNPA2 levels were ascertained using
100 µg of protein frommtDNA-depleted cells and 500 µg of protein from
control cells for immunoprecipitation. The nuclear and cytosolic
fractions were immunoprecipitated overnight at 4 °C, with the respec-
tive antibodies (2 µg/ml) as mentioned in the ﬁgure legends. The
immune complexes were collected onto protein A-agarose beads and
washed extensively (Sigma-Aldrich, St. Louis, MO). The immunopreci-
pitates were extracted from the beads with 2× Laemmli's buffer devoid
of β-mercaptoethanol at 95 °C for 5 min and used for further analysis.
2.13. ChIP analysis
ChIP assays were performed following the protocol of Millipore
(Billerica, MA). Brieﬂy, protein–DNA complexes in vivo were ﬁxed by
adding 1% formaldehyde to the culture medium and incubated at
37 °C for 10 min. The cell pellet was suspended in SDS lysis buffer [1%
SDS, 10 mM EDTA, and 50 mM Tris, pH 8.1], and the cell lysates were
sonicated using an ultrasonic processor sonicator (10-s pulses; 20
times, on ice). Diluted aliquots were immunoprecipitated with
respective antibodies overnight at 4 °C. Preimmune IgG was used as
a negative control, and equal volumes of samples were used as input
DNA. The antibody–chromatin complex was immunoprecipitated by
protein G-agarose/salmon sperm DNA (50% slurry) (Sigma-Aldrich).
The DNA recovered after the reversal of cross-linking was ampliﬁed
by real-time PCR using promoter speciﬁc primers. Data were analyzed
by normalizing with the corresponding input values.
2.14. Electrophoretic mobility shift assays
DNA–protein binding was assayed using 0.1 pmol (30,000 cpm) of
32P-end-labeled double-stranded Cathepsin L promoter DNA (220 bp,
sequence −273 to −53). The following double-stranded DNA
sequences from Cathepsin L promoter were used as competitors: C/
EBPδ binding site, WT: GCCAATGAC and Mut: GACTACGAC; NFκB
binding site, WT: GGTGGAAATTC and Mut: GATGCGAATCC. Binding
reactions (20 μl ﬁnal volume) were run at room temperature for
20 min using 15 μg of nuclear extracts and/or indicated amounts of
puriﬁed hnRNPA2 and 1 μg of poly (dI–dC). The DNA bound
complexes were resolved by electrophoresis on 3.8% polyacrylamide
gel using 0. 5× TBE running buffer. Competing DNAs (20–30 pmol)
were added to the reaction mixture before adding the probe DNA.
2.15. Akt activity
The Akt activity was measured using Akt/PKB kinase activity assay
kit (Stressgen Bioreagents, Victoria, BC, Canada). This assay is based
on ELISA which utilizes a synthetic peptide as PKB substrate and a
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2.16. In vitro kinase assay
The in vitro kinase assay was done according to the methods of
Summers et al. [34]. Recombinant Akt (Millipore) 0.5 µg was
incubated with puriﬁed 6× his-hnRNPA2 (1.0 µg) at 37 °C for
30 min. The level of protein phosphorylation was assessed by SDS
gel electrophoresis followed by ﬂuorography.
3. Results
3.1. Mitochondrial respiratory stress activates calcineurin and calcium
responsive factors
Mitochondria regulate the pattern of Ca2+ transients following Ca2+
inﬂux and release of Ca2+ from intracellular stores [35–37]. In recent
studies we showed that mitochondrial stress conditions, which disrupt
Δψm, cause a steady and sustained increase in cytoplasmic free Ca2+
([Ca2+]c) [3,9]. The levels of Ca2+ responsive cytoplasmic and nuclear
factors, as well as the steady state levels of proteins implicated in cell
invasion and apoptosis in mtDNA-depleted and reverted cells were
studied.Matrix protease Cathepsin L is an importantmarker for invasive
tumors [38]. Similarly, TGFβ has been shown to be important in
inducing the invasive behavior in several tumor cells [9]. Immunoblot
analysis of post-nuclear protein fraction showed that the levels of both
Cathepsin L and TGFβ are three to six times higher in mtDNA-depleted
cells (Fig. 1) [9]. Ca2+and calmodulin responsive factor calcineurinwere
increased three to ﬁve fold in mtDNA-depleted cells, but the level was
reversed to near control levels in reverted cells. Increased Cn level in
mtDNA-depleted cells is closely linked to mitochondrial respiratory
stress in these cells since restoration ofmtDNA content also reverted the
Cn activity to near control cell level. The levels of Ca2+ storage proteins
calreticulin and calsequestrin were also two to four fold higher in
mtDNA-depleted cells. The level of Na+/K+ ATPase, used as a loading
control, remained the same in all three cell types ((Fig. 1A).
Calcineurin is a cytoplasmic, Ca2+-dependent, protein phosphatase,
which is implicated in Ca2+-mediated inﬂammatory response, apopto-
sis and cardiac hypertrophy [39–41]. The catalytic subunit CnA depho-
sphorylates and activates target proteins belonging to NFAT family of
transcription factors, such as NFATc [41]. Fig. 1A shows that the steady
state levels of the catalytic subunit CnAα in the post-mitochondrial
fraction of mtDNA-depleted is induced ∼10-fold, and returned to nearFig. 1. Activation of mitochondrial stress factors in mtDNA-depleted C2C12 cells.
A. Immunoblot analysis of post-nuclear fractions of control, mtDNA-depleted and
reverted C2C12 cells. 30 µg protein in each was subjected to immunoblot analysis as
described in the Materials and methods section. Blots were quantiﬁed using a BioRad
imager. B. Calcineurin activity in post-nuclear fraction was assayed using a kit from
Upstate Biologicals as described in theMaterials andmethods section. FK506was added
at 10 nM level. Results represent average±SEM of three separate assays.normal levels (∼2-fold of normal) in reverted cells. In contrast, the level
of Na+/K+ ATPase protein used as an internal control remained nearly
the same in all samples. Fig. 1B shows the activity of calcineurin was
about 2.5 fold higher in mtDNA-depleted cells. This activity was
abolished inmtDNA-depleted cells by treatmentwith FK506 treatment.
Notably, the general phosphatase activity in mtDNA-depleted cells
appears to be lower than in control cells as seen by the extent of
inhibition by FK506. The reason for this change remains unclear.
3.2. Mitochondrial respiratory stress-induced glucose uptake and
resistance to apoptosis through IGF1R activation
A number of studies have shown that inhibition of mitochondrial
respiratory chain-linked oxidative metabolism causes a metabolic
shift to increased glycolysis possibly as a compensatory mechanism.
Consistent with this, mtDNA-depleted cells showed N2-fold higher
basal glucose uptake compared with control cells (Fig. 2A). Mito-
chondrial stress by treatment with mitochondrial ionophore CCCP,
which disrupts Δψm also resulted in a ∼2.5-fold higher glucose
uptake. However, glucose uptake in reverted cells is reduced to near
control cell levels suggesting a link between mitochondrial dysfunc-
tion and metabolic shift. FK506, an inhibitor of Cn, inhibited glucose
uptake by control and reverted cells only marginally (15 and 20%,
respectively), but to a markedly higher extent of 70% in mtDNA-
depleted cells suggesting that the increased 2-DOG uptake in mtDNA-
depleted cells is mediated by calcineurin.
In keeping with the results of glucose uptake, mtDNA-depleted
cells show a 3- to 4-fold higher mRNA level of the glucose transporter
GLUT4 (Fig. 2B). IR and IGF1R both activate GLUT4 and glucose uptake
in C2C12 cells. By treatment with speciﬁc inhibitors and siRNA, we
determined that IGF1R, and not IR, was preferentially activated under
mitochondrial stress [26]. Although not shown, autophosphorylation
of IR was markedly lower in mtDNA-depleted cells compared to
control cells. Fig. 2C shows that IGF1R mRNA is 10 folds higher in
mtDNA-depleted cells. Moreover, silencing Cn mRNA by siRNA in
mtDNA-depleted cells markedly reduces the expression of both Glut4
and IGF1R indicating the regulation of both these factors upstream by
calcineurin (Fig. 2B and C).
Fig. 2D (top panel) shows a nearly 7 fold higher activation/
phosphorylation of IGF1R in mtDNA-depleted C2C12 cells and this
increase is reversed by Cn inhibitor FK506. FK506 treatment fails to
exert such an effect on receptor phosphorylation in control and
reverted cells. We also observed that activation of IGF1R is a common
phenomenon in different cell types subjected to mitochondrial stress.
Fig. 2D lower panels show that in A549, 3T3 and H9C2 cells, metabolic
stress induced by CCCP treatment results in increased IGF1R levels.
Although not shown IGF1 levels are also increased inmtDNA-depleted
cells suggesting an autocrine regulation of glucose uptake.
MtDNA-depleted cells are resistant to apoptosis. In Fig. 2E, we
measured cellular apoptosis using the Nexin assay which uses
annexin V-PE to detect phosphatidylserine on the plasma membrane
as an indicator of apoptotic cells. The Nexin assay in Fig. 2E showed
only marginal increase in apoptosis by IR mRNA silencing, whereas
IGF1R mRNA silencing caused a vastly increased (∼50%) apoptosis
which strongly suggests that IGF1R activation is important for cell
survival under mitochondrial stress.
3.3. Transcriptional upregulation of nuclear genes under mitochondrial
stress
We analyzed the minimal promoter regions of mitochondrial stress
responsive target genes Cathepsin L (marker for tumor invasion), RyR1
(maintains calcium homeostasis), and Glut4 (glucose transport) for
common binding sites of stress-activated transcription factors, NFκB,
NFAT, CREB and C/EBPδ. Nucleotide sequence analysis using MatInspec-
tor indicated that RyR1 and Glut4 promoters also contained consensus
Fig. 2. Increased glucose uptake and activation of IGF1R pathway in mtDNA-depleted C2C12 cells. A. 2-deoxyglucose uptake was measured in control, mtDNA-depleted and reverted
cells as described in the Materials and methods section. In some cases mitochondrial respiratory stress was induced by adding 25 µM CCCP to control cells as indicated. FK506 was
added at 10 nM concentration. B. Effects of CnAαmRNA knock down on Glut4 mRNA level. Real-time PCR analysis of Glut4 mRNA was carried out with total RNA from control and
mtDNA-depleted cells with or without expressing siRNA for CnAαmRNA. C. Effects of CnAαmRNA knock down on IGF1R mRNA level. Real-time PCR analysis of IGF1R mRNA from
control andmtDNA-depleted cells expressing siRNA for CnAαmRNA or “scrambled” siRNA. D. IGF1R levels under mitochondrial stress. Immunoblot analysis of post-nuclear fractions
of control, depleted and reverted C2C12 cells (top panel), A549 (control and mtDNA-depleted), 3T3 and H9C2 cells treated with 25 µM CCCP to induce stress. FK506 was added at
10 nM concentration. E. Effects of 1GF1R and IR mRNA knock down on apoptotic cell death were measured using the Nexin assay kit as described in the Materials and methods
section. Results (% cell death) show average±SEM of three separate estimates.
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response regions (Fig. 3A). The RyR1 and Cathepsin L promoters also
contained NFAT consensus sites (Fig. 3A). Theminimal promoter regions
of the three stress target genes containing sites with full or partial
consensus for binding to NFκB, C/EBPδ, CREB, and NFAT factors was used
to transfect control and mtDNA-depleted cells (Fig. 3B). All the three
genes Cathepsin L, RyR1 and Glut4 showed between 2 and 4 fold higher
luciferase activity inmtDNA-depleted cells over control. In reverted cells,
the promoter activity was markedly reduced to near control cell level
indicating that the increase in promoter activity inmtDNA-depleted cells
was due to mitochondrial stress.
We reported that mitochondrial stress activates a novel IκBβ
mediated NFκB pathway [6,16]. Fig. 3C shows the contribution of IkBα
and β on the relative levels of mRNAs for Glut4, IGF1R and RyR1 that
are the known targets of stress signaling. IκBβ silencing resulted in
marked reduction of Glut4, RyR1 and IGF1R mRNAs in mtDNA-
depleted cells. IκBα silencing has no effect on Glut4 and RyR1 mRNA
levels, though IGF1R mRNA levels were clearly affected. These results
suggest that IGF1R expression is regulated by both classical NFκB
pathway and mitochondrial stress-mediated, calcineurin requiring,
pathway. As shown in Table 1 nearly 40 additional genes ﬁt the
criteria of genes induced by mitochondrial stress speciﬁc NFκB
pathway since the steady state levels of these genes in mtDNA-
depleted cells is reduced by IκBβ silencing but not by IκBα silencing.
The genes upregulated in mtDNA-depleted cells but downregulated
by IκBβ silencing include genes involved in cellularmetabolism, signal
transduction, cellular redox function, ion transport, mitochondrial
genetics, cell adhesion, cell cycle and tumorigenesis (Table 1).
We used the enhanceosome pull-down approach [33] to determine
the nuclear proteins that bind to theminimal stress response regions of
Cathepsin L promoter. Approximately 1 mg of nuclear protein was
loaded on each column, and the proteins from mtDNA-depleted and
control C2C12 cells were eluted with buffer containing progressively
higher salt (0.2–0.4 M KCl), and proteins were resolved by SDS-PAGE.Fig. 3D shows the immunoblot of Cathepsin L promoter DNA bound
proteins from the nuclear extracts of mtDNA-depleted cells. Although
not shown, nano LC-MS/MS analysis of promoter DNA bound proteins
identiﬁed C/EBPδ, (cRel, p50), NFAT and hnRNPA2 as the prominent
proteins associated with the enhanceosome. As seen from Fig. 3D, these
same proteins were indentiﬁed byWestern blot analysis. It is seen that
most of the bound proteins were eluted by buffers containing 0.2 and
0.3 M NaCl. The immunoblot shows that although cRel is more
preferentially eluted at 0.2 M NaCl, its putative partner p50 is eluted
more preferentially at 0.3 M NaCl. The reason for this differential salt
requirement of these two proteins remains unclear. Results also show
very low level of p65 binding but robust levels of cRel and p50 binding
suggesting selectivity of NFκB factors for promoter DNA binding.
HnRNPA2 is involved in mRNA processing, RNA transport and RNA
metabolism. Immunoblot in Fig. 3E shows that in control, mtDNA-
depleted, and reverted C2C12 cells, the levels of hnRNPA2 is
signiﬁcantly higher in the nucleus than in the cytoplasmic compart-
ment. Additionally, the protein level was almost 5 fold higher in the
nuclear fraction of mtDNA-depleted cells compared to control cells.
Reverted cells showed a near control cell level of hnRNPA2 protein
(∼1.5 fold higher than in control cells). Consistent with the protein
levels, hnRNPA2mRNA levels were also increased in mtDNA-depleted
cells by nearly 5 fold and were brought down to near control cell level
in reverted cells (Fig. 3E). These results together show that increased
hnRNPA2 expression inmtDNA-depleted cells is indeed in response to
mitochondrial stress due to mtDNA depletion.
3.4. HnRNPA2 as a coactivator of mitochondrial stress responsive nuclear
target genes
Coimmunoprecipitation experiments have shown that hnRNPA2
physically associates with other stress-activated transcription factors,
namely, C/EBPδ, NFκB (cRel:p50), NFAT, and CREB in the nuclear
fraction of mtDNA-depleted cells. To understand the functional
Fig. 3. Analysis of minimal promoters of stress target genes and characterization of protein factors involved in transcription regulation. A. Maps of minimal promoters of mouse
Cathepsin L, RyR1, human Glut4 promoter and locations of sites for binding to the signature factors. B. Transcriptional activity of the minimal promoter regions of stress response
genes in control, mtDNA-depleted and reverted cells. C. Effects of IκBα and IκBβmRNA depletion on the levels of mRNAs for Glut4, IGF1R and RyR1 genes in mtDNA-depleted cells.
D. Characterization of protein factors binding to the minimal promoter DNA of Cathepsin L promoter. Immunoblot of fractions eluted at different salt concentrations were developed
using factor speciﬁc antibodies as described in the Materials and methods section. E. Top panel: Immunoblot analysis of hnRNPA2 levels in nuclear and cytosolic fractions of control,
mtDNA-depleted and reverted cells using hnRNPA2 speciﬁc antibody. Actin was used as loading control for cytosolic protein and p97 was used for nuclear protein. Bottom panel:
Real-time PCR analysis of hnRNPA2 mRNA levels in control, mtDNA-depleted and reverted C2C12 cells.
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andmtDNA-depleted cells cotransfectedwith cDNAs for individualDNA
binding factors (cRel, C/EBP δ, CREB) in combination with hnRNPA2
(Fig. 4A). Luciferase activity driven by the Cathepsin L promoterwas 1.8,
2.5, 1.5, and 1.7 fold higher over basal levels after cRel, C/EBPδ, CREB,
and hnRNPA2 transfections, respectively (Fig. 4A). Transfection of
control cells also modestly increased luciferase activity. Cotransfections
of hnRNPA2 cDNA with either cRel or C/EBPδ enhanced luciferase
activity by several fold, suggesting a possible cooperativity between
hnRNPA2 and the two DNA binding factors (Fig. 4A).
To ascertain the in vivo association of stress-activated transcription
factors and hnRNP A2 at the target promoters, we performed ChIP
assays in control, mtDNA-depleted and mtDNA-depleted/hnRNPA2-
silenced cells. ChIP analysis in Fig. 4B shows an increased association
of cRel, C/EBPδ, CREB, and hnRNPA2 with the Cathepsin L promoter in
mtDNA-depleted cells. In contrast, hnRNPA2 silencing in mtDNA-
depleted cells resulted in marked and uniform reduction in factor
binding to the Cathepsin L promoter (Fig. 4B). ChIP analysis in Fig. 4C
also shows that hnRNPA2 association with Cathepsin L promoter is
reduced to near normal cell level in reverted cells. These results are
consistentwith the return of hnRNPA2 protein andmRNA levels when
the mtDNA content is reverted back to near control cell level and
provide a rigorous evidence that increased hnRNPA2 occupancy of
Cathepsin L promoter site is directly related to mitochondrial stress.
HnRNPA2 is an RNA-binding protein [42] and its ability to bind to
dsDNA in a sequence speciﬁc or non-speciﬁc manner remainsunknown. To further understand the functional role of hnRNPA2,
we carried out electrophoretic mobility shift assay (EMSA) with the
220 bp Cathepsin L promoter DNA as a probe (Fig. 4D). The EMSA
pattern in Fig. 4D shows that extract from mtDNA-depleted cells
formed a prominent slow migrating complex while extract from
control cells yielded a complex of markedly lower intensity. Notably,
silencing of hnRNPA2 mRNA in mtDNA-depleted cells vastly reduced
the intensity of the complex (lane 4). Use of higher amount of
recombinant protein (2.5 µg) also did not result in formation of the
slowmigrating complex although some complexes possibly reﬂecting
non-speciﬁc binding were seen (lane 5). However, addition of
recombinant hnRNPA2 (1.0 µg) to the nuclear extract from mtDNA-
depleted/hnRNPA2 silenced cells formed an intense slow migrating
complex (lane 6). Competition with individual factor binding DNA
motifs such as NFκB and C/EBPδ (lanes 7 and 8), but not the mutated
DNA motifs (lanes 9 and 10), reduced the intensity of the complex.
These results indicate that binding of various signature factors is
either inter-dependent or cooperative and secondly, hnRNPA2 plays a
critical role in the binding.
3.5. Reversal of stress-induced invasive behavior and gene expression by
hnRNPA2 silencing
We showed that hnRNPA2 has a role in the activation of stress
speciﬁc marker genes, Cathepsin L, RyR1 and Glut4 [14]. We
conﬁrmed its contribution by silencing hnRNP A2 in control and
Table 1
Genes regulated by IκBβ during mitochondrial respiratory stress signaling.
Gene title Gene symbol Fold change (depl vs. cont) Fold change (depl vs. depl IκBβ KD)
Tumor marker proteins
Melanoma cell adhesion molecule Mcam 26.1938 −2.12697
Melanoma antigen Mela 14.4641 1.01304
Tumor progression proteins
Breast cancer anti-estrogen resistance 1 Bcar1 2.47854 1.12202
Transforming growth factor, β2 Tgfb2 2.2924 −1.50422
Metabolism regulatory proteins
Carbonic anhydrase 8 Car8 22.0069 1.15188
Insulin-like growth factor 2, binding protein 1 Igf2bp1 10.4676 −1.40136
Pyruvate dehydrogenase kinase, isoenzyme 1 Pdk1 4.12998 −1.52081
Pyruvate carboxylase Pcx 3.2003 1.04495
Phosphofructokinase, platelet Pfkp 3.1962 −1.65984
Pyruvate dehydrogenase kinase, isoenzyme 3 Pdk3 2.50058 −1.45416
Cytoskeletal proteins
Procollagen, type IV, α1 Col4a1 6.88394 −1.07038
Procollagen, type IV, α2 Col4a2 6.23115 1.0008
Connective tissue growth factor Ctgf 5.01523 −1.53219
Cell/mitochondrial function/signaling proteins
Cytochrome c oxidase, subunit VIIa 1 Cox7a1 5.82145 −1.89848
Nitric-oxide synthase 1, neuronal (Nos1), mRNA Nos1 8.47653 −1.24509
Synuclein, α Snca 9.44693 −2.23639
Ubiquitin-activating enzyme E1-like Ube1l 7.93742 −1.3696
Mitogen-activated protein kinase kinase kinase 1 Map3k1 4.30808 −1.76614
Glycogen synthase 1, muscle/glycogen synthase 3, brain Gys1/Gys3 3.21247 −1.39839
Superoxide dismutase 2, mitochondrial Sod2 2.47852 −1.19618
Translocase of inner mitochondrial membrane 9 homolog (yeast) Timm9 2.37736 −1.51778
Phosphatidylinositol 3-kinase, C2 domain-containing, α polypeptide Pik3c2a 2.3394 −1.56545
Calcium regulation proteins
Inositol 1,3,4-triphosphate 5/6 kinase Itpk1 3.88386 −1.25792
Calcium channel, voltage-dependent, P/Q type, α 1A subunit Cacna1a 2.73045 −2.07777
FK506-binding protein 5 Fkbp5 1.89555 −1.40141
Depl = depleted cells; cont = control cells.
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We detected increase of 2.5 fold in Cathepsin L, 4 fold in RyR1 and 4.2
fold in Glut 4 luciferase activity in mtDNA-depleted cells over the
control cells (Fig. 5A). These increases were effectively blunted by
hnRNPA2 mRNA silencing in mtDNA-depleted cells without any
signiﬁcant decrease in control cells.
We have shown previously that the increased invasiveness of
mtDNA-depleted cells is associated with activation of IGF1R pathway
and increased glucose uptake [26]. Fig. 5B shows that siRNA-mediated
knock down of hnRNPA2 reduced glucose uptake to near control cell
levels, suggesting that hnRNPA2 protein also plays an important role
in the cellular metabolic shift triggered by mitochondrial respiratory
stress.
Previous studies have shown that cells subjected to mitochondrial
stress exhibit higher growth rates and invasion.We used these cells to
test the effect of hnRNPA2 depletion. Equal numbers of cells
(1×104cells) were seeded and cell viability was assessed at 24 h
intervals. At 24 h, mtDNA-depleted cells showed nearly same growth
rate as control and mtDNA-depleted/hnRNPA2 silenced cells. How-
ever, by 48 h mtDNA-depleted cells had grown signiﬁcantly more
than the mtDNA-depleted/hnRNPA2 silenced cells, which were
comparable to control C2C12 cells (Fig. 5C). Matrigel invasion in
Fig. 5D shows that after 24 h mtDNA-depleted cells have a
signiﬁcantly higher invasion compared to control cells. This pattern
reverts to control levels in mtDNA-depleted/hnRNPA2 silenced cells.
3.6. Akt1 is activated by mitochondrial stress and phosphorylates
hnRNPA2
Previous reports have suggested that phosphorylation of hnRNPA2
is important for maintaining the transformed state of tumor cells
[43,44]. To evaluate the level of hnRNP A2 phosphorylation in control
andmtDNA-depleted cells, we used the same input levels of hnRNPA2from both cell types for immunoprecipitation. The immunoblot in
Fig. 6A shows increased Ser-phosphorylation of nuclear hnRNPA2.
To identify the kinase involved, we focused on Akt which
is downstream of IGF1R/PI-3 kinase. Sequence analysis using
PhosphoScan revealed two putative Akt phosphorylation sites (Thr
98 and Ser 219) on hnRNPA2 (Fig. 6B top panel). We investigated the
signiﬁcance of these two sites for Akt1-dependent phosphorylation
using recombinant hnRNPA2 and Akt. Gel proﬁle in Fig. 6B shows the
in vitro kinase assay of puriﬁed hnRNPA2 with and without Akt1 in
presence of 32γ[ATP]. We show that hnRNPA2 is a substrate for
phosphorylation by Akt.
Akt is activated in tumorigenic cells [45] and therefore we checked
the levels of Akt in cells subjected to mitochondrial stress by mtDNA
depletion which develop tumorigenic phenotype. As shown in Fig. 6C,
Akt1 mRNA level in C2C12 cells was increased by ∼2 fold in cells
subjected to mitochondrial stress (mtDNA depletion and CCCP
treatment) as compared to control cells. In reverted cells, Akt1
mRNA level reduced to 1.5 fold of control cells indicating that this
increase is a direct response to mitochondrial respiratory stress.
Fig. 6D shows that Akt activity is increased by about 2.5 fold in the
total lysate and nuclear fractions of mtDNA-depleted cells. However,
there was only a marginal increase in Akt activity in the cytosolic
fraction of mtDNA-depleted cells.
To understand the signiﬁcance of Akt phosphorylation on nuclear
functions of hnRNPA2, we silenced Akt1 mRNA and protein to 70% by
siRNA in C2C12 cells and assessed the promoter occupancy of
hnRNPA2 by ChIP analysis (Fig. 6E). ChIP analysis using these cells
showed that hnRNPA2 occupancy of the Cathepsin L promoter was
reduced by b75% in mtDNA-depleted cells as compared to companion
cells expressing mock siRNA.
These results provide direct evidence for the role of Akt1 in
transcription activation of stress response genes and mitochondrial
stress-induced recruitment of hnRNPA2 to the target gene promoter.
Fig. 4.HnRNPA2 binds to the enhanceosome by protein–protein interaction and functions as a transcription coactivator. A. Transcriptional activity of Cathepsin L promoter in control
andmtDNA-depleted, andmtDNA-depleted/hnRNPA2 knock down cells. The promoter construct was cotransfected with indicated cDNAs as described in the Materials andmethods
section. B. ChIP analysis of the Cathepsin L promoter with hnRNPA2, hnRNPD-L, C/EBPδ, cRel, and CREB antibodies in the indicated cells. C. ChIP analysis of Cathepsin L promoter in
control, mtDNA-depleted and reverted cells using hnRNPA2 antibody. In both B and C, preimmune serum was used as a negative antibody control. Real-time PCR analysis using 10%
input DNA for normalization. Values are expressed as folds relative to the factor binding in control cells. D. Gel mobility shift analysis using the Cathepsin L minimal promoter DNA
and either puriﬁed recombinant hnRNPA2 or nuclear extracts from control, mtDNA-depleted and mtDNA-depleted/hnRNPA2 knock down cells (15 µg protein from nuclear extract
and 1.0 to 2.5 µg puriﬁed hnRNPA2 protein). Unlabeled WT and mutant DNAs (20 fold molar excess) were used for competition.
Fig. 5. Role of hnRNPA2 in transcription modulation and in vitro invasive behavior of cells subjected to mitochondrial stress. A. Luciferase activity of Cathepsin L, Glut4 and RyR1
promoters in control, mtDNA-depleted and mtDNA-depleted/hnRNPA2 knock down cells. Transfection with promoter DNAs and measurement of luciferase activities were
described in Materials and methods. B. 2-Deoxyglucose uptake in control, mtDNA-depleted and mtDNA-depleted/hnRNPA2 knock down cells. C. Effects of mtDNA depletion and
hnRNPA2 knock down on cell growth. Number of viable cells was measured using the Guava cell counter. D. In vitro invasion patterns of control, mtDNA-depleted/mock siRNA, and
mtDNA-depleted/hnRNPA2 siRNA cells through the Matrigel.
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Fig. 6. Activation of Akt1 and Akt1 mediated phosphorylation of hnRNPA2 in cells subjected to mitochondrial stress. A. Immunoblot analysis of nuclear protein from control and
mtDNA-depleted cells for phosphorylated hnRNPA2 using hnRNPA2 and phospho-Ser antibodies. B. Top panel shows the structural and functional domain of hnRNPA2. The
autoradiogram at the bottom shows recombinant Akt1-mediated phosphorylation of puriﬁed hnRNPA2. C. Akt1 mRNA quantitation by real-time PCR in control, mtDNA-depleted,
CCCP-treated and reverted cells. D. Akt activity was measured in the nuclear extract of control and mtDNA-depleted cells using an Akt assay kit as described in the Materials and
methods section. E. ChIP analysis of Cathepsin L promoter in control, mtDNA-depleted/mock siRNA and mtDNA-depleted/AktsiRNA cells for occupancy of hnRNPA2.
Fig. 7. A model for mitochondrial respiratory stress-induced activation of nuclear gene
expression and altered physiological processes.
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Induced expression of genes encoding mitochondria-destined
proteins in response to mitochondrial dysfunction either due to
mtDNA mutations or exposure to chemical agents has been observed
by several groups in different mammalian cells [6,7,10,46]. More
recent studies using differential mRNA display, cDNA array analysis or
use of proteomics approach have shown that wide spectrum of genes
encoding mitochondrial respiratory complex proteins, cell surface
receptors, proteins involved in apoptosis, and transcription regulation
are either up or downregulated in cells completely lacking mtDNA (ρo
cells) or partially depleted of mtDNA ([6,7,9] and Table 1). In
extension of these studies we describe a detailed mechanism by
which mitochondrial respiratory stress modulates nuclear gene
expression and identiﬁed a set of common protein factors that are
essential for stress speciﬁc transcription modulation. Additionally we
also describe cellular processes including increased dependence of
cells for glucose, resistance to apoptosis, increased invasive behavior
of cells and altered cell morphology that are affected as part of this
respiratory stress.
We deﬁne mitochondrial stress as altered mitochondrial trans-
membrane potential by treatment with mitochondria speciﬁc iono-
phore CCCP and/or, depletion of mitochondrial DNA, which induces a
unique calcineurin-mediated signaling culminating in the altered
nuclear gene proﬁle and invasive phenotypes in otherwise non-
invasive cells (Fig. 7). Depletion of mitochondrial ATP levels by
treatment with oligomycin did not induce stress signaling (results not
shown) further conﬁrming the need for disruption of Δψm for the
induction of stress signaling. The nuclear genes affected by this
signaling are diverse in their function and include genes involved in:1) maintaining calcium regulation/homeostasis—RyR1, Calsequestrin,
and Calreticulin; 2) invasiveness and oncogenesis—Cathepsin L, TGFβ,
Akt, p53, andmousemelanoma antigen; 3) glucose metabolism—IGF1
receptor, IRS-1, GLUT 4, and hexokinase; 4) cellular apoptosis—Akt1,
PI3-K, Bcl 2, Bid, BAD and Bax [3,5,6,9,11,15,18,26,27,46–50].
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important landmarks of this signaling [5,6,16,26]. We have also
shown that nuclear C/EBPδ, CREB and NFAT are also activated in
response to respiratory stress [10,14]. We show here that hnRNPA2 is
a critical transcription coactivator which is important for the regula-
tion of stress responsive genes suggesting that it represents another
critical landmark of this pathway. We show that hnRNPA2, plays a
critical role in the functional cooperativity of DNA binding signature
factors, and functions as a novel transcription coactivator of respira-
tory stress signaling pathway.
HnRNPA2was originally described as an RNA-binding proteinwith
possible role in mRNA maturation, transport and other aspects of
nuclear RNA processing [42]. More recent studies show that hnRNPA2
and other members of the hnRNP family may have roles in other
cellular processes including telomere function, cell proliferation and
oncogenesis [44,51,52]. There is mounting evidence implicating
hnRNPA2 in a variety of cancers, including lung, breast, and pancreatic
cancer [26,32,51]. HnRNPA2 has been found to associate with many
oncogenic proteins (TDP-43, TOG2, and SET) in tumor cells [53–56],
although the functional relevance of these interactions has remained
unclear until now. In this paper we propose that hnRNPA2 also
functions as a transcription coactivator.
It was recently shown that other members of hnRNP family such as
hnRNP K participate in the transcription regulation of genes involved
in UV-induced DNA damage [57]. It was shown that hnRNP K
manifests its transcription activator function by directly binding to
promoter DNA in a sequence speciﬁc manner and also by association
with other DNA bound transcription activators [57]. In repeated
attempts wewere unable to detect any signiﬁcant DNA binding ability
of hnRNPA2 from the nuclear fractions of control or mtDNA-depleted
C2C12 cells. This was true with DNA from minimal promoter regions
of the stress target genes RyR1, Cathepsin L or Glut4 shown in Fig. 3A
or non-speciﬁc double-stranded DNA. Bacterially expressed and
puriﬁed hnRNPA2 formed minor non-speciﬁc (fast migrating) com-
plexes with Cathepsin L promoter DNA. Puriﬁed hnRNPA2, however
induced the formation of a prominent slow migrating complex with
extracts from hnRNPA2 knock down cells that was also seen with
extract from mtDNA-depleted cells containing full complement of
hnRNPA2. Additionally, DNA motifs corresponding to the putative C/
EBPδ and cRel:p50 binding sites competed with the slow migrating
complex. These results and also results of ChIP analysis suggest that
hnRNPA2 associates with the DNA bound factors (C/EBPδ, cRel:p50,
NFAT and CREB)mostly by protein–protein interactions. In this regard
hnRNPA2 is different from other members of hnRNP family proteins
which also function as transcription coactivators. Notably, stress-
mediated transcription modulation requiring the action of hnRNPA2
is also important for tumor progression and in vitro invasion through
the Matrigel membrane since stable or transient knock down of
hnRNPA2 not only abrogated the propagation of signaling, but also
reversed the invasive phenotypes of mtDNA-depleted cells.
Our previouswork has shown that cells subjected tomitochondrial
stress develop resistance to apoptosis whichwas also accompanied by
shift in the metabolic pattern of cells. We have shown that the
metabolic shift to glycolysis in these cells involves a switch from
insulin to the IGF1 receptor mediated signaling [26], which appears to
be autocrine type of regulation. In continuation of this study we show
here that altered metabolic shift also causes increased nuclear
accumulation and activation of Akt under mitochondrial stress.
Other reports have shown that nuclear translocation of p-Akt is
considered to be of particular signiﬁcance in tumor progression [58].
Additionally, some recent studies implicate activation of Akt in
mtDNA-depleted prostate and other tumor cells in increased
invasiveness of these cells [59,60]. Our results on Akt1 activation in
mtDNA-depleted C2C12 cells are consistent with these published
results. Results presented in this paper, however extend these
observations by linking its direct role in the phosphorylation andactivation of transcription coactivator, hnRNPA2. We show that Akt1
knock down not only reduced the promoter occupancy of hnRNPA2,
but also transcription activation of mitochondrial stress responsive
target genes. Our results here suggest that Akt phosphorylates
mitochondrial stress-activated coactivator hnRNPA2 and regulates
its occupancy of target gene promoters.
In summary we present a common mechanism for the mitochon-
drial respiratory stress-mediated transcriptional modulation of
several nuclear genes that affect multiple cellular processes as
shown in Fig. 7. As indicated, mitochondrial respiratory stress alters:
1. Glucose uptake and utilization by activating IGF1R and PI-3 kinase
pathway [26]. 2. Resistance to apoptosis possibly through activation of
Akt1 kinase system. 3. Reprogramming of nuclear gene expression
pattern through activation of four signature factors (C/EBPδ, cRel:p50,
NFAT, CREB) and recruitment of hnRNPA2 in an Akt1 kinase
dependent manner. The genes affected include those involved in
cell proliferation, oncogenesis and cell invasion. 4. As shown before,
the stress signaling also causes major changes in cytoskeletal
organization, development of pseudopodia-like structures, and
altered organization of FAK on microtubular assembly [6,27]. We
believe that the mechanism we describe here is important in
understanding cellular response to altered mitochondrial function
and bioenergetic system.References
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